Tomáš Maršálek, MBA

Prepare for Meeting →

Founding Partner

i&i Bio

Check size: €150K for company creation and roughly €500K-€2M for initial venture investments, as published by i&i Bio.

Investment Thesis

Tomáš Maršálek, MBA invests or supports investment decisions through i&i Bio's published strategy: Invest in scientifically strong early-stage life-science companies, with primary focus on Central and Eastern Europe and selective opportunities across Europe.

What Excites Them

Validated science, protectable intellectual property, credible translational plans and founders who can move discoveries toward clinical or commercial milestones.

What They Pass On

No formal pass list is public. Projects without strong scientific validation, life-science relevance or a feasible development path appear less aligned.

How to Pitch

Present the science, validation, IP, development and regulatory path, team, milestone budget and why i&i Bio's regional network matters.

Notable Writing

No writing has been linked yet. Kit can search for posts, interviews, and fund essays worth reading before outreach.

Podcast Appearances

No podcast appearances are linked yet. Ask Kit to check for interviews that reveal how this investor thinks.

Key Quotes

Quote coverage is incomplete. Kit can look for direct comments on markets, founders, and investment criteria.

Background

Tomáš Maršálek, MBA is a current Founding Partner at i&i Bio. i&i Bio says he has more than 15 years in fund management, venture capital and private equity, with expertise in valuation, due diligence and tax structuring.

Share
Requests are processed by our agent pipeline nightlyIs this you? Request removal